Literature DB >> 8505002

Ovarian surface epithelium and human ovarian cancer.

J Dietl1, K Marzusch.   

Abstract

Approximately 80-90% of adult ovarian cancers are assumed to originate from ovarian surface cells. The morphology of the ovarian surface epithelium changes constantly, exhibiting features such as crypts, inclusion cysts, villous processes and different forms of müllerian epithelium. The unique nature of ovarian surface features and their absence in the immediately adjacent peritoneal mesothelium suggest that local factors may play an important part in modifying the growth and morphology of the ovarian surface epithelium. Recent studies tend to emphasize oncogene activation, along with concomitant cytogenetic changes, in the development of ovarian cancer. This review focuses on the roles of exogenous and endogenous factors and ovulation in the pathogenesis of ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8505002     DOI: 10.1159/000292682

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  4 in total

1.  Estradiol regulates E-cadherin mRNA levels in the surface epithelium of the mouse ovary.

Authors:  C D MacCalman; R Farookhi; O W Blaschuk
Journal:  Clin Exp Metastasis       Date:  1994-07       Impact factor: 5.150

2.  Low-Stage High-Grade Serous Ovarian Carcinomas: Support for an Extraovarian Origin.

Authors:  Elizabeth Morency; Mario M Leitao; Robert A Soslow
Journal:  Int J Gynecol Pathol       Date:  2016-05       Impact factor: 2.762

3.  Novel population of small tumour-initiating stem cells in the ovaries of women with borderline ovarian cancer.

Authors:  Irma Virant-Klun; Martin Stimpfel
Journal:  Sci Rep       Date:  2016-10-05       Impact factor: 4.379

4.  Enhanced efficacy and specificity of epithelial ovarian carcinogenesis by embedding a DMBA-coated cloth strip in the ovary of rat.

Authors:  Yiping Huang; Wei Jiang; Yisheng Wang; Yufang Zheng; Qing Cong; Congjian Xu
Journal:  J Ovarian Res       Date:  2012-09-03       Impact factor: 4.234

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.